B. J. Nankivell and D. R. Kuypers, Diagnosis and prevention of chronic kidney allograft loss, Lancet, vol.378, issue.9800, p.22000139, 2011.

L. D. Cornell, R. N. Smith, and R. B. Colvin, Kidney transplantation: mechanisms of rejection and acceptance, Annu Rev Pathol, vol.3, p.18039144, 2008.

P. F. Halloran, Immunosuppressive drugs for kidney transplantation, N Engl J Med, vol.351, issue.26, p.15616206, 2004.
DOI : 10.1056/nejmra033540

X. C. Li and L. A. Turka, An update on regulatory T cells in transplant tolerance and rejection, Nat Rev Nephrol, vol.6, issue.10, p.20683480, 2010.

S. Sakaguchi, M. Miyara, C. M. Costantino, and D. A. Hafler, FOXP3+ regulatory T cells in the human immune system, Nat Rev Immunol, vol.10, issue.7, pp.490-500, 2010.

S. Segundo, D. Millan, O. Munoz-cacho, P. Boix, F. Paz-artal et al., High proportion of pretransplantation activated regulatory T cells (CD4+CD25highCD62L+CD45RO+) predicts acute rejection in kidney transplantation: results of a multicenter study, Transplantation, vol.98, issue.11, p.25083613, 2014.

F. Braza, E. Dugast, I. Panov, C. Paul, K. Vogt et al., Central Role of CD45RA-Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance, J Am Soc Nephrol, vol.26, issue.8, p.25556168, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02147767

C. Braudeau, M. Racape, M. Giral, S. Louis, A. Moreau et al., Variation in numbers of CD4 +CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome

, Transpl Int, vol.20, issue.10, p.17854443, 2007.

J. R. Silkensen, Long-term complications in renal transplantation, J Am Soc Nephrol, vol.11, issue.3, p.10703683, 2000.

M. J. Bottomley and P. N. Harden, Update on the long-term complications of renal transplantation, Br Med Bull, vol.106, pp.117-151, 2013.

E. A. Engels, R. M. Pfeiffer, J. F. Fraumeni, B. L. Kasiske, A. K. Israni et al., Spectrum of cancer risk among US solid organ transplant recipients, JAMA, vol.306, issue.17, p.22045767, 2011.

E. Au, G. Wong, and J. R. Chapman, Cancer in kidney transplant recipients, Nat Rev Nephrol, vol.14, issue.8, p.29802400, 2018.

J. Dantal and M. Campone, Daunting but Worthy Goal: Reducing the De Novo Cancer Incidence After Transplantation, Transplantation, vol.100, issue.12, p.27861286, 2016.

C. M. Hope, B. S. Grace, K. R. Pilkington, P. T. Coates, I. P. Bergmann et al., The immune phenotype may relate to cancer development in kidney transplant recipients, Kidney Int, vol.86, issue.1, p.24429406, 2014.

R. P. Carroll, D. S. Segundo, K. Hollowood, T. Marafioti, T. G. Clark et al., Immune phenotype predicts risk for posttransplantation squamous cell carcinoma, J Am Soc Nephrol, vol.21, issue.4, pp.713-735, 2010.

W. H. Fridman, F. Pages, C. Sautes-fridman, and J. Galon, The immune contexture in human tumours: impact on clinical outcome, Nat Rev Cancer, vol.12, issue.4, pp.298-306, 2012.

M. Y. Mapara and M. Sykes, Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance, J Clin Oncol, vol.22, issue.6, p.15020616, 2004.

A. Moreau, E. Varey, I. Anegon, and M. C. Cuturi, Effector mechanisms of rejection, Cold Spring Harb Perspect Med, vol.3, issue.11, p.24186491, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02166030

A. J. Lam, R. E. Hoeppli, and M. K. Levings, Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation, Transplantation, vol.101, issue.10, p.28376037, 2017.

M. C. Clark and L. G. Baum, T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival, Ann N Y Acad Sci, vol.1253, p.22288421, 2012.

M. L. Hermiston, Z. Xu, and A. Weiss, CD45: a critical regulator of signaling thresholds in immune cells, Annu Rev Immunol, vol.21, p.12414720, 2003.

E. Picarda, S. Bezie, L. Boucault, E. Autrusseau, S. Kilens et al., Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells, JCI Insight, vol.2, issue.3, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01833115

L. Ordonez, I. Bernard, M. Chabod, J. F. Augusto, V. Lauwers-cances et al., A higher risk of acute rejection of human kidney allografts can be predicted from the level of CD45RC expressed by the recipients' CD8 T cells, PLoS One, vol.8, issue.7, p.23894540, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02164657

L. Ordonez, I. Bernard, L. Faqihi-olive, F. E. Tervaert, J. W. Damoiseaux et al., CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients, PLoS One, vol.4, issue.4, 2009.

J. F. Subra, B. Cautain, E. Xystrakis, M. Mas, D. Lagrange et al., The balance between CD45RChigh and CD45RClow CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled, J Immunol, vol.166, issue.5, p.11207243, 2001.

M. Haas, B. Sis, L. C. Racusen, K. Solez, D. Glotz et al., Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am J Transplant, vol.14, issue.2, p.24472190, 2014.

E. Xystrakis, P. Cavailles, A. S. Dejean, B. Cautain, C. Colacios et al., Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat, J Immunol, vol.173, issue.5, p.15322174, 2004.

P. Gatault, N. Kamar, M. Buchler, C. Colosio, D. Bertrand et al., Reduction of ExtendedRelease Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study, Am J Transplant, p.27862923, 2016.

J. F. Augusto, J. F. Subra, C. Onno, F. Villemain, A. Croue et al., Long-term maintenance immunosuppressive regimen with tacrolimus monotherapy, Ann Transplant, vol.18, p.23872516, 2013.